Literature DB >> 25477291

Body mass index and waist circumference are independent risk factors for low vital capacity among Japanese participants of a health checkup: a single-institution cross-sectional study.

Yoko Goto1, Hirohide Yokokawa, Hiroshi Fukuda, Toshio Naito, Teruhiko Hisaoka, Hiroshi Isonuma.   

Abstract

OBJECTIVE: This study aimed to examine the associations between obesity and percentage vital capacity (%VC), as well as lifestyle-related disorders, among Japanese participants of a voluntary health checkup.
METHODS: Subjects were 7,892 individuals who participated in a medical health checkup from January to December 2007. Multivariate logistic regression analysis was performed to assess associations between low %VC (<80) and body mass index (BMI) and waist circumference (WC), as well as lifestyle-related disorders.
RESULTS: Medical histories of hypertension and dyslipidemia were more frequent in the low %VC group than in the normal %VC group in both sexes. In men, BMI was significantly associated with low %VC (25.0 ≤ C2 < 27.5, odds ratio (OR) = 2.10; 27.5 ≤ C3 < 30.0, OR = 2.23; C4 ≥ 30.0, OR = 3.46) relative to the first category (C1 < 25.0). A significant association was also observed between WC and low %VC (85 ≤ C2 < 90, OR = 1.40; 90 ≤ C3 < 95, OR = 1.55; 95 ≤ C4, OR = 2.51; relative to C1 < 85.0 cm). In women, BMI was significantly associated with low %VC in C3 and C4 (C3, OR = 2.05; C4, OR = 2.84), and WC was significantly associated with low %VC in C4 (C4, OR = 2.32).
CONCLUSION: Our results suggest that obesity may be associated with restrictive pulmonary function and underscore the importance of maintaining ideal body weight for the prevention of restrictive pulmonary dysfunction.

Entities:  

Mesh:

Year:  2014        PMID: 25477291      PMCID: PMC4597343          DOI: 10.1007/s12199-014-0431-5

Source DB:  PubMed          Journal:  Environ Health Prev Med        ISSN: 1342-078X            Impact factor:   3.674


  19 in total

Review 1.  The effect of obesity on chronic respiratory diseases: pathophysiology and therapeutic strategies.

Authors:  Magali Poulain; Mariève Doucet; Geneviève C Major; Vicky Drapeau; Frédéric Sériès; Louis-Philippe Boulet; Angelo Tremblay; François Maltais
Journal:  CMAJ       Date:  2006-04-25       Impact factor: 8.262

2.  Vital capacity as a predictor of incident type 2 diabetes: the Atherosclerosis Risk in Communities study.

Authors:  Hsin-Chieh Yeh; Naresh M Punjabi; Nae-Yuh Wang; James S Pankow; Bruce B Duncan; Frederick L Brancati
Journal:  Diabetes Care       Date:  2005-06       Impact factor: 19.112

3.  Lung function, insulin resistance and incidence of cardiovascular disease: a longitudinal cohort study.

Authors:  G Engström; B Hedblad; P Nilsson; P Wollmer; G Berglund; L Janzon
Journal:  J Intern Med       Date:  2003-05       Impact factor: 8.989

4.  Prospective association between lung function and the incidence of diabetes: findings from the National Health and Nutrition Examination Survey Epidemiologic Follow-up Study.

Authors:  Earl S Ford; David M Mannino
Journal:  Diabetes Care       Date:  2004-12       Impact factor: 19.112

5.  Low vital capacity is associated with diabetes despite inverse relationships with metabolic risk factors in lean Japanese men.

Authors:  Eiji Oda; Ryu Kawai
Journal:  Intern Med       Date:  2009-07-15       Impact factor: 1.271

6.  A cross-sectional relationship between vital capacity and metabolic syndrome and between vital capacity and diabetes in a sample Japanese population.

Authors:  Eiji Oda; Ryu Kawai
Journal:  Environ Health Prev Med       Date:  2009-07-22       Impact factor: 3.674

7.  Abdominal obesity and respiratory function in men and women in the EPIC-Norfolk Study, United Kingdom.

Authors:  D Canoy; R Luben; A Welch; S Bingham; N Wareham; N Day; K T Khaw
Journal:  Am J Epidemiol       Date:  2004-06-15       Impact factor: 4.897

8.  A possible association between suspected restrictive pattern as assessed by ordinary pulmonary function test and the metabolic syndrome.

Authors:  Kei Nakajima; Yoichi Kubouchi; Toshitaka Muneyuki; Midori Ebata; Satoko Eguchi; Hiromi Munakata
Journal:  Chest       Date:  2008-07-14       Impact factor: 9.410

9.  The association between metabolic syndrome and restrictive ventilatory dysfunction in older persons.

Authors:  Filippo Luca Fimognari; Patrizio Pasqualetti; Leo Moro; Alessandro Franco; Gianfranco Piccirillo; Ruggero Pastorelli; Paolo Maria Rossini; Raffaele Antonelli Incalzi
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2007-07       Impact factor: 6.053

10.  Contribution of six risk factors to achieving the 25×25 non-communicable disease mortality reduction target: a modelling study.

Authors:  Vasilis Kontis; Colin D Mathers; Jürgen Rehm; Gretchen A Stevens; Kevin D Shield; Ruth Bonita; Leanne M Riley; Vladimir Poznyak; Robert Beaglehole; Majid Ezzati
Journal:  Lancet       Date:  2014-05-02       Impact factor: 79.321

View more
  3 in total

1.  Relationship of normal-weight central obesity with the risk for heart failure and atrial fibrillation: analysis of a nationwide health check-up and claims database.

Authors:  Kensuke Ueno; Hidehiro Kaneko; Kentaro Kamiya; Hidetaka Itoh; Akira Okada; Yuta Suzuki; Satoshi Matsuoka; Katsuhito Fujiu; Nobuaki Michihata; Taisuke Jo; Norifumi Takeda; Hiroyuki Morita; Junya Ako; Koichi Node; Toshimasa Yamauchi; Hideo Yasunaga; Issei Komuro
Journal:  Eur Heart J Open       Date:  2022-04-13

2.  Associated Factors and Comorbidities of Airflow Limitation in Subjects Undergoing Comprehensive Health Examination in Japan - Survey of Chronic Obstructive Pulmonary Disease Patients Epidemiology in Japan (SCOPE- J).

Authors:  Hisamitsu Omori; Noritaka Higashi; Takeshi Nawa; Toshiki Fukui; Toshihiko Kaise; Takeo Suzuki
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-11-23

3.  Performance of body mass index and body fat percentage in predicting metabolic syndrome risk factors in diabetic patients of Yazd, Iran.

Authors:  Marzieh Shukohifar; Zohre Mozafari; Masoud Rahmanian; Masoud Mirzaei
Journal:  BMC Endocr Disord       Date:  2022-08-31       Impact factor: 3.263

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.